Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.

Collaboration to Safeguard Maternal and Child Health: Sansure and UNICEF Mongolia Establish a Strategic Partnership
2025-12-11

On December 2, 2025, the Sansure Mongolia team and Mr. Evariste Kouassi-Komlan, Representative of UNICEF Mongolia, signed a Memorandum of Understanding in Ulaanbaatar, marking the formal commencement of bilateral cooperation in the field of maternal and child health safeguards in Mongolia, this initiative brings professional medical expertise to advance the wellbeing of women and children across the region! This partnership […]

LEARN MORE
Advancing with the Nation, Cultivating ASEAN|Sansure’s Malaysia Market Development: From Infectious Disease Diagnostics Provider to Global Public Health Partner
2025-07-25

As the bustling crowd gradually dispersed from the exhibition hall, the three-day World Health Expo Kuala Lumpur concluded successfully. As Asia’s largest medical laboratory exhibition, the event featured over 450 exhibitors and attracted more than 10,000 attendees. This global gathering of healthcare leaders not only showcased cutting-edge medical innovations but also served as a vital platform for Chinese medical brands expanding internationally. Sansure captivated […]

LEARN MORE
From Freetown to Changsha: A Health Pact Spanning Ten Thousand Miles! He Reveals How Chinese Technology Ignites Africa’s Public Health Hope
2025-06-27

On June 24, Dr. Sartie Kenneh, Chief Medical Officer of Sierra Leone’s Ministry of Health, led a delegation to visit Sansure accompanied by Dr. Zhihui Chen, member and medical team leader of The 25th batch of the Chinese medical team in Sierra Leone. The visit aims to deepen cooperation in public health, particularly in cervical cancer prevention and control, and […]

LEARN MORE
Sansure Supports Sierra Leone in Achieving a Historic Breakthrough in Cervical Cancer Prevention and Control
2025-03-17

Recently, Sierra Leone achieved a significant breakthrough in cervical cancer prevention and control. The country’s first-ever cervical cancer HPV screening project results announcement and award ceremony was held at the Ministry of Health of Sierra Leone. The project was led by the 25th batch of the Chinese (Hunan) medical aid team to Sierra Leone, with Sansure Biotech supplying HPV screening […]

LEARN MORE
Bridging Borders Through Science: China and Mongolia Forge New Frontiers in Medical Diagnostics
2024-10-31

In the sprawling landscape of international medical cooperation, where knowledge flows like a vital current across continents, Sansure and Mongolia’s National Center for Public Health (NCPH) have orchestrated a symphony of scientific exchange that reverberates across the steppes of Central Asia. This partnership aspires not only to share expertise but to construct a more comprehensive diagnostic ecosystem, nurture laboratory professionals, […]

LEARN MORE
1 2 3 11
×
Get in touch with us
I confirm that I have reviewed Sansure's Privacy Policy and agree with the collection and storage of my personal data.
SUBMIT

Thank you!

We shall contact you soon!
Back Top